drugset / Trial / NCT05615467
A Study of Effect of LY3556050 on Metformin in Healthy Participants
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The main purpose of this study is to evaluate how much Metformin gets into the bloodstream and how long the body takes to get rid of it when it is administered orally in combination with LY3556050 in healthy participants. Iohexol will be administered to evaluate kidney function. Each enrolled participant will remain in the study for up to 7 weeks including the screening period.
Timeline
- Start
- 2022-11-15
- Primary completion
- 2022-12-27
- Completion
- 2022-12-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iohexol | Diagnostic / imaging agent | — | Intravenous |
| Subject | LY3556050 | Unknown | — | Oral |
| Subject | Metformin | Small molecule | — | Oral |
Indications
No indication recorded.